|Bid||4.1400 x 1100|
|Ask||4.1500 x 1100|
|Day's Range||4.0000 - 4.1800|
|52 Week Range||0.8200 - 4.2000|
|Beta (5Y Monthly)||2.69|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 03, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jan 29, 2016|
|1y Target Est||3.17|
Rhizome Partners, a long-term capital investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 18.2% was recorded by the fund for the Q4 of 2020, outperforming its S&P 500 benchmark that delivered a 12.2% return. You can view the fund’s top 5 […]
Calumet Specialty Products Partners, L.P. ("Calumet," the "Partnership" or the "Company") (NASDAQ: CLMT) today announced that Jennifer G. Straumins has been elected as a director of Calumet GP, LLC, the general partner of the Partnership, effective February 12, 2021. Ms. Straumins is replacing her father, F. William Grube, who passed away on November 24, 2020.
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (the "Partnership," "Calumet," "we," "our" or "us") announced today that it plans to report results for the fiscal fourth quarter and full year 2020 on March 3, 2021. A conference call to discuss the financial and operational results is scheduled for March 3, 2021 at 9:00 AM ET.